Associations between changes in dopamine and noradrenaline transporters and clinical symptoms in patients with ADHD taking methylphenidate - Associations between changes in dopamine and noradrenaline transporters and clinical symptoms in patients with ADHD taking methylphenidate

Department of Functional Brain Imaging National Institute of Radiological Sciences National Institutes for Quantum and Radiological Science and Technology0 sites50 target enrollmentFebruary 1, 2020

ConditionsADHD

Overview

Phase: 未知
Intervention: Not specified
Conditions: ADHD
Sponsor: Department of Functional Brain Imaging National Institute of Radiological Sciences National Institutes for Quantum and Radiological Science and Technology
Enrollment: 50
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

February 1, 2020

End Date

March 31, 2024

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Department of Functional Brain Imaging National Institute of Radiological Sciences National Institutes for Quantum and Radiological Science and Technology

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Subjects with severe physical, or other psychiatric diseases Subjects with strong suicidal ideation Subjects during (probable) pregnancy or breast\-feeding Subjects who were judged not suitable for other reasons